Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/1995
11/02/1995CA2188543A1 Compounds and methods for the stimulation and enhancement of protective immune responses and il-12 production
11/02/1995CA2188470A1 Multirepresentation of a peptide analogue of the dppiv substrate, especially of the kpr type, to inhibit the entry of hiv in cells
11/02/1995CA2188418A1 Genetic sequences conferring disease resistance in plants and uses therefor
11/02/1995CA2188397A1 Human sperm diagnostic
11/02/1995CA2188395A1 Heparin-binding protein for the treatment of sepsis and processes for its preparation
11/02/1995CA2188391A1 Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides
11/02/1995CA2188258A1 Human gamma 3 gaba-a receptor subunit and stably co-transfected cell lines
11/02/1995CA2187920A1 Spider neurotoxins and method of producing the same
11/02/1995CA2177066A1 Red blood cell surrogate
11/01/1995CN1111058A Inhibitor of collagen-stimulated platelet aggregation
10/1995
10/31/1995US5463029 Adsorbing, eluting on cationic exchange resin, followed by same on anionic exchange resin
10/31/1995US5463028 Compound comprising a methyl ecgonine group chemically attached to a phenylphosphonic group which is an analog to an intermediate of the hydrolysis transition-state of a cocaine benzoyl ester group
10/31/1995US5463026 Anti-human prohibitin antibodies
10/31/1995US5463025 Protein having human plasmin inhibiting activity
10/31/1995US5463024 Antigen-presenting assembled particle comprising protein molecules of self-assembling, particle-forming polypeptide encoded by gag gene of retrovirus fused to polypeptide defining viral, bacterial or protozoal antigenic epitope
10/31/1995US5463023 Composition for inhibition of intracellular transcription
10/31/1995US5462939 Treating infectious diseases, septic shock, respiratory diseases, inflammatory conditions, autoimmune diseases, bone diseases
10/31/1995US5462927 Peptides aiding nerve regeneration
10/31/1995US5462926 Inhibiting inositol phosphate by contacting cells with an octapeptide
10/31/1995US5462925 Transforming growth factor β2,3
10/31/1995US5462872 Human lymphoid cells expressing human immunodeficiency virus envelope protein GP160
10/31/1995US5462871 Nonapeptides bind to human leukocyte antigens on cell surfaces leading to lysis by cytolytic T lymphocytes
10/31/1995US5462863 Isolation of Hepatitis B surface antigen from transformed yeast cells
10/31/1995US5462862 Antibiotics from microorganisms
10/31/1995US5462856 Methods for identifying chemicals that act as agonists or antagonists for receptors and other proteins involved in signal transduction via pathways that utilize G-proteins
10/31/1995US5462852 Contacting lysate of biological sample with detectable amount of antibody specifically reactive with p7 antigen or fragment for time and under conditions for forming antigen-antibody complex, determining presence of complex to indicate infection
10/31/1995US5462752 Inhibition of platelet binding
10/31/1995US5462751 Biological and pharmaceutical agents having a nanomeric biodegradable core
10/31/1995US5462750 Metal, ceramic or polymeric particles coated with sugars or oligonucleotides which adsorb active materials, for drug delivery or medical diagnosis
10/31/1995US5462734 Parenteal administering first vaccination containing bovin herpese virus glycoprotein capable of systemic immune response and a carrier, second vaccine with cholera toxin adjuvant capable of mucosal immune response applied to mucosa tissues
10/31/1995US5462732 Method of protecting plants from insects by applying gypsy moth virus with enhanced polyhedra production stability
10/30/1995CA2122874A1 Neural receptor tyrosine kinase
10/28/1995CA2147933A1 Transgenic animals as a model for metabolic bone diseases
10/26/1995WO1995028642A1 A method for detecting the presence of a mycobacterium species and a kit and antibodies for use therein
10/26/1995WO1995028499A1 Nucleic acid encoding transcription factor p300 and uses of p300
10/26/1995WO1995028497A1 Interaction of proteins involved in a cell death pathway
10/26/1995WO1995028494A1 Gene delivery fusion proteins
10/26/1995WO1995028493A1 Aav-mediated delivery of dna to cells of the nervous system
10/26/1995WO1995028488A1 NON-SPLICING VARIANTS OF gp350/220
10/26/1995WO1995028487A2 Recombinant pgp3, methods of preparation and use in diagnosis and therapy
10/26/1995WO1995028486A2 Recombinant proteins of filamentous haemagglutinin of bordetella, particularly bordetella pertussis, method for producing same, and uses thereof for producing foreign proteins or vaccinating active principles
10/26/1995WO1995028485A1 Erbb2 promoter binding protein in neoplastic disease
10/26/1995WO1995028484A1 Hek5, hek7, hek8, hek11, new eph-like receptor protein tyrosine kinases
10/26/1995WO1995028483A1 Cell-cycle regulatory proteins, and uses related thereto
10/26/1995WO1995028481A1 Conserved t-cell receptor sequences
10/26/1995WO1995028478A1 Rps2 gene and uses thereof
10/26/1995WO1995028474A1 Dna encoding bradykinin b1 receptor
10/26/1995WO1995028427A1 Chimeric interleukin-3/mutein interleukin-6 lymphokine
10/26/1995WO1995028426A2 Peptides for reducing or inhibiting bone resorption, angiogenesis and restenosis
10/26/1995WO1995028425A1 Preventive for circulatory diseases
10/26/1995WO1995028424A1 Pharmaceutical peptide formulations for treatment of dust mite allergy
10/26/1995WO1995028423A1 Rps gene family, primers, probes, and detection methods
10/26/1995WO1995028422A1 Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors
10/26/1995WO1995028415A1 Method of protein and peptide cleavage
10/26/1995WO1995028411A1 Sequence encoding mammalian sulfonylurea receptor and method of detecting persistent hyperinsulinemic hypoglycemia of infancy
10/26/1995WO1995028172A1 Human bone stimulating factor
10/26/1995WO1995028170A1 Icam-1/lfa-1 short-chain peptides and method of using same
10/26/1995WO1995028169A1 Tumor suppressor gene and methods for detection of cancer, monitoring of tumor progression and cancer treatment
10/26/1995WO1995028166A2 Method for implanting encapsulated cells in a host
10/26/1995WO1995014091A3 Compositions and methods for utilizing conditionally lethal genes
10/26/1995DE4447484A1 APO-1 inhibitor compsn. inhibits apoptosis
10/26/1995CA2189028A1 Hek5, hek7, hek8, hek11, new eph-like receptor protein tyrosine kinases
10/26/1995CA2188316A1 Recombinant pgp3, methods of preparation and use in diagnosis and therapy
10/26/1995CA2188287A1 Icam-1/lfa-1 short-chain peptides and method of using same
10/26/1995CA2188182A1 Conserved t-cell receptor sequences
10/26/1995CA2188180A1 Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors
10/26/1995CA2188172A1 Human bone stimulating factor
10/26/1995CA2187945A1 Sequence encoding mammalian sulfonylurea receptor and method of detecting persistent hyperinsulinemic hypoglycemia of infancy
10/26/1995CA2187818A1 Gene delivery fusion proteins
10/26/1995CA2187779A1 A method for detecting the presence of a mycobacterium species and a kit and antibodies for use therein
10/26/1995CA2187771A1 Rps gene family, primers, probes, and detection methods
10/26/1995CA2187642A1 Peptides for reducing or inhibiting bone resorption, angiogenesis and restenosis
10/26/1995CA2187335A1 Method for implanting encapsulated cells in a host
10/26/1995CA2186639A1 Cell-cycle regulatory proteins, and uses related thereto
10/25/1995EP0678744A2 Method for detecting urinary tumor associated antigens
10/25/1995EP0678578A2 Multiple drug resistance gene of Aureobasidium pullulans
10/25/1995EP0678577A2 Method for the production of recombinant human LH-RH receptor proteins
10/25/1995EP0678522A1 Insulin analogs
10/25/1995EP0678122A1 Recombinant anti-vla4 antibody molecules
10/25/1995EP0678121A1 Methods and reagents for inhibiting furin endoprotease
10/25/1995EP0678102A1 Process for the purification and refolding of human respiratory syncytial virus fg glycoprotein
10/25/1995EP0678101A1 Growth differentiation factor-9
10/25/1995EP0678100A1 Synthetic amphipathic peptides with antimicrobial activity
10/25/1995EP0678031A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof
10/25/1995EP0678028A1 Dna encoding a human betaine/gaba transporter and uses thereof
10/25/1995EP0678018A1 Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides
10/25/1995EP0598832A4 Dna sequencing with a t7-type gene 6 exonuclease.
10/25/1995EP0565704A4 Synthetic peptides corresponding to portions of hiv-2 virus and methods of using in an improved assay
10/25/1995EP0506818B1 Method of covalently bonding proteins to hydrophilic surfaces
10/25/1995EP0434836B1 Method for purifying tenascin
10/25/1995EP0433378B1 ALLELIC VARIANTS OF $i(PLASMODIUM FALCIPARUM) MEROZOITE SURFACE ANTIGEN
10/25/1995EP0294392B1 Diagnostic and therapeutic antibody conjugates
10/24/1995US5461142 Phosphorylated derivatives of cardiodilatin/ANF peptides
10/24/1995US5461035 Short peptides with insulin activity
10/24/1995US5461034 Osteogenic growth polypeptides identified from regenerating bone marrow
10/24/1995US5461032 Insecticidally effective peptides
10/24/1995US5461031 Monomeric insulin analog formulations
10/24/1995US5461029 Method of treating herpes viral infections using HBNF and MK proteins
10/24/1995US5460978 Protein active in humoral hypercalcemia of malignancy-PthrP
10/24/1995US5460977 Peptide having allergenicity
1 ... 2575 2576 2577 2578 2579 2580 2581 2582 2583 2584 2585 2586 2587 2588 2589 2590 2591 2592 2593 2594 2595 ... 2916